← Full program

Closing Discussion

Part of Oral Abstract Highlight Session #1

Details

Date
Friday, January 22, 2027
Time
11:54 AM – 12:00 PM
Session type
Concurrent Session
Schedule
See this day

About

This session showcases the highest-ranking oral abstracts, highlighting the most impactful and innovative research in neuromodulation. Designed to provide attendees with a forward-looking perspective, it features emerging evidence and transformative ideas that are shaping the future of the field. Participants will gain valuable insights into evolving trends, novel approaches, and key advancements that are poised to influence research, clinical practice, and innovation in neuromodulation.

Presenters

  • Paul Lynch, MD, Interventional Pain Physician, Fellowship Trained, DABA

    Paul Lynch, MD, Interventional Pain Physician, Fellowship Trained, DABA

    Founder and CEO

    US Pain Care · Scottsdale, Arizona

    Paul Lynch, MD, is the founder and CEO of US Pain Care, a vertically integrated
    healthcare company that provides strategy, marketing, and management support to
    healthcare practices, vendors, and insurance companies. US Pain Care focuses on
    evidence-based clinical protocols that reduce costs while also providing life-changing
    care to patients suffering from chronic pain.
    He is additionally the founder and CEO of Nirvana, a healthcare billing and compliance
    company that utilizes emerging technologies such as artificial intelligence and machine
    learning to decrease the cost of revenue cycle management while simultaneously
    increasing compliance.
    Dr. Lynch is a double board-certified and fellowship-trained pain management physician
    and anesthesiologist, with 17 years’ experience treating all types of chronic pain
    conditions. He has managed pain practices in 15 different states and is currently licensed
    to practice in 9 states. He also has experience as an expert witness, performing legal
    reviews and providing deposition testimony since 2010, with involvement in over 100
    cases.
    Dr. Lynch’s personal goal is to help save 1 million lives through US Pain Care’s
    innovative approach to treating those suffering from chronic pain and opioid use disorder.